Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE)
| 0.4309 Delayed Data As of Mar 23 |  -0.0391 / -8.32%Today’s Change | 0.39 Today|||52-Week Range 2.28 | -18.70% Year-to-Date |
Latest ZYNE News | Press Releases
No recent news for Zynerba Pharmaceuticals Inc.
Today’s Trading
| Previous close | 0.47 |
| Today’s open | 0.45 |
| Day’s range | 0.43 - 0.45 |
| Volume | 5,800 |
| Average volume (3 months) | 331,256 |
| Market cap | $19.1M |
Data as of 3:13pm ET, 03/23/2023
Growth & Valuation
| Earnings growth (last year) | +49.98% |
| Earnings growth (this year) | +13.46% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.24 |
Competitors
Data as of 3:54pm ET, 03/23/2023
Financials
| Last reporting date | March 24, 2023 |
| EPS forecast (this quarter) | -$0.19 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$37.3M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Devon, Pennsylvania |
Forecasts
